Pre-diagnostic cognitive and functional impairment in multiple sporadic neurodegenerative diseases

被引:20
|
作者
Swaddiwudhipong, Nol [1 ,2 ]
Whiteside, David J. [1 ,2 ]
Hezemans, Frank H. [1 ,3 ]
Street, Duncan [1 ]
Rowe, James B. [1 ,2 ,3 ]
Rittman, Timothy [1 ,2 ]
机构
[1] Dept Clin Neurosci, Herchel Smith Bldg,Robinson Way, Cambridge CB2 0SZ, England
[2] Univ Cambridge, Cambridge Univ Hosp NHS Trust, Cambridge, England
[3] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England
关键词
Alzheimer's disease; cognition; dementia; dementia with Lewy bodies; frontotemporal dementia; multiple system atrophy; neurodegenerative disease; Parkinson disease; physical function; pre-diagnostic; progressive supranuclear palsy; sporadic; UK Biobank; FALSE DISCOVERY RATE; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; SYSTEM ATROPHY; R PACKAGE; DIAGNOSIS; BETA; TAU;
D O I
10.1002/alz.12802
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction The pathophysiological processes of neurodegenerative diseases begin years before diagnosis. However, pre-diagnostic changes in cognition and physical function are poorly understood, especially in sporadic neurodegenerative disease. Methods UK Biobank data were extracted. Cognitive and functional measures in individuals who subsequently developed Alzheimer's disease (AD), Parkinson disease, frontotemporal dementia, progressive supranuclear palsy, dementia with Lewy bodies, or multiple system atrophy were compared against individuals without neurodegenerative diagnoses. The same measures were regressed against time to diagnosis, after adjusting for the effects of age. Results There was evidence for pre-diagnostic cognitive impairment and decline with time, particularly in AD. Pre-diagnostic functional impairment and decline were observed in multiple diseases. Discussion The scale and longitudinal follow-up of UK Biobank participants provides evidence for cognitive and functional decline years before symptoms become obvious in multiple neurodegenerative diseases. Identifying pre-diagnostic functional and cognitive changes could improve selection for preventive and early disease-modifying treatment trials.
引用
收藏
页码:1752 / 1763
页数:12
相关论文
共 50 条
  • [1] Cerebral microbleeds and cognitive impairment in neurodegenerative and cerebrovascular diseases
    Makotrova, T.
    Arablinskiy, A.
    Trusova, N.
    Vasenina, E.
    Levin, O.
    JOURNAL OF NEUROLOGY, 2014, 261 : S179 - S179
  • [2] Cerebral microbleeds and cognitive impairment in neurodegenerative and cerebrovascular diseases
    Makotrova, T.
    Arablinskiy, A.
    Trusova, N.
    Vasenina, E.
    Levin, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 260 - 260
  • [3] Molecular dynamics of cognitive-motor impairment in neurodegenerative diseases
    Kumar, Dhiraj
    Noor, Saba
    Alam, Manzar
    Hassan, Md Imtaiyaz
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2023, 16
  • [4] Neurons, Nose, and Neurodegenerative Diseases: Olfactory Function and Cognitive Impairment
    Fatuzzo, Irene
    Niccolini, Giovanni Francesco
    Zoccali, Federica
    Cavalcanti, Luca
    Bellizzi, Mario Giuseppe
    Riccardi, Gabriele
    de Vincentiis, Marco
    Fiore, Marco
    Petrella, Carla
    Minni, Antonio
    Barbato, Christian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [5] Persisting importance of pre-diagnostic adversities to cognitive and behavioural vulnerabilities in "epilepsy only"
    Jennekens-Schinkel, A
    Oostrom, KJ
    Smeets-Schouten, A
    Peters, ACB
    van Teeseling, H
    EPILEPSIA, 2003, 44 : 46 - 46
  • [6] Cognitive impairment in neurodegenerative diseases: A trans-diagnostic approach using a lesion-symptom mapping analysis
    Morais, Ricardo Felix
    Pires, Ricardo
    Jesus, Tiago
    Lemos, Raquel
    Duro, Diana
    Lima, Marisa
    Baldeiras, Ines
    Oliveira, Tiago Gil
    Santana, Isabel
    NEUROSCIENCE, 2025, 573 : 214 - 227
  • [7] Cognitive correlates of antisaccade behaviour across multiple neurodegenerative diseases
    Riek, Heidi C.
    Brien, Donald C.
    Coe, Brian C.
    Huang, Jeff
    Perkins, Julia E.
    Yep, Rachel
    McLaughlin, Paula M.
    Orange, Joseph B.
    Peltsch, Alicia J.
    Roberts, Angela C.
    Binns, Malcolm A.
    Lou, Wendy
    Abrahao, Agessandro
    Arnott, Stephen R.
    Beaton, Derek
    Black, Sandra E.
    Dowlatshahi, Dar
    Finger, Elizabeth
    Fischer, Corinne E.
    Frank, Andrew R.
    Grimes, David A.
    Kumar, Sanjeev
    Lang, Anthony E.
    Lawrence-Dewar, Jane M.
    Mandzia, Jennifer L.
    Marras, Connie
    Masellis, Mario
    Pasternak, Stephen H.
    Pollock, Bruce G.
    Rajji, Tarek K.
    Sahlas, Demetrios J.
    Saposnik, Gustavo
    Seitz, Dallas P.
    Shoesmith, Christen
    Steeves, Thomas D. L.
    Strother, Stephen C.
    Sunderland, Kelly M.
    Swartz, Richard H.
    Tan, Brian
    Tang-Wai, David F.
    Tartaglia, Maria Carmela
    Turnbull, John
    Zinman, Lorne
    Munoz, Douglas P.
    BRAIN COMMUNICATIONS, 2023, 5 (02)
  • [8] Reading impairment in neurodegenerative diseases: a multiple single-case study
    Ripamonti, Enrico
    Lucchelli, Federica
    Lazzati, Gaia
    Martini, Eleonora
    Luzzatti, Claudio
    APHASIOLOGY, 2017, 31 (05) : 519 - 541
  • [9] A comparative study of cognitive impairment in sporadic and familial cases of multiple sclerosis
    Niakosari, Vida
    Namjoo-Moghadam, Ali
    Abin, Ahmad Ali
    Poursadeghfard, Maryam
    Hashemi, Sana
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [10] MicroRNA: A Linking between Astrocyte Dysfunction, Mild Cognitive Impairment, and Neurodegenerative Diseases
    Ramirez, Angelica E.
    Gil-Jaramillo, Natalia
    Alejandra Tapias, Maria
    Gonzalez-Giraldo, Yeimy
    Pinzon, Andres
    Puentes-Rozo, Pedro J.
    Felipe Aristizabal-Pachon, Andres
    Gonzalez, Janneth
    LIFE-BASEL, 2022, 12 (09):